Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma.

ABSTRACT:

SUBMITTER: Howarth P 

PROVIDER: S-EPMC7592754 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature